The global contraceptives market is anticipated to reach USD 29.62 billion by 2028, recording a CAGR of 4.6% from 2021 to 2028, according to The Insight Partners. The Intrauterine Product (IUDs) segment is expected to drive growth during 2021-2028. The market report covers product, end-user, and distribution channel segments for the contraceptive market. It provides insights into market strategies impacting growth, competitive landscape, and key developments in the market. Pregna International Limited, Mayer Laboratories, Inc., Medicines360, and Cupid Limited are among the key companies operating in the contraceptives market.
Sexually transmitted diseases (STDs) have a significant effect on sexual and reproductive health globally. As per the WHO, over one million sexually transmitted infections (STIs) are acquired every day worldwide. The contraceptive methods have shown to alter the risk of acquiring STDs. Spermicides, condoms, and diaphragms all have been reported to provide protection against gonorrhea, chlamydia, and pelvic inflammatory disease in vivo. The rising awareness for sexually transmitted diseases is likely to promote the use of contraceptives for preventing unwanted pregnancies and preventing STDs.
North America accounted for the largest share of the global contraceptive market in 2020. The contraceptives market growth in this region is owing to awareness among the population, prevention of unwanted pregnancies, and increasing product developments by key players in the region. The US held the largest share of the North American contraceptives market in 2020, with initiatives such as the Teen Pregnancy Prevention Program, which targeted groups with high teen pregnancy rates. Increasing product launches in the US is likely to fuel the market growth during the forecast period.
